MarketPulse — Real-Time Financial News & Market Analysis

Pomerantz launches class action against Vistagen after failed clinical trial caused 80% stock drop. March 16, 2026 deadline for investors to join lawsuit.

Class action lawsuit filed against China Liberal Education for alleged securities fraud involving fraudulent social media advisors that artificially inflated stock prices before collapse.

Newmont shares fell 3% as Asian holiday closures disrupted gold trading and prices weakened below $4,900/oz, with investor caution ahead of Fed minutes.

Leidos beat earnings but shares fell 6% due to disappointing revenue and weak 2026 guidance, reflecting government budget uncertainties and operational challenges.

Oracle faces securities lawsuit for allegedly misrepresenting AI infrastructure investment returns and failing to disclose significant financial obligations and project delays.

Anthropic's new Claude model intensifies concerns about AI disrupting traditional software business models, triggering an $830 billion market cap decline in the sector.

Ralliant Corporation faces securities investigation over $1.4B impairment charge. Stock plunged 31.8%, raising questions about delayed disclosure of material information to investors.

REGENXBIO faces securities lawsuit over alleged false statements about gene therapy safety. Investors have until April 14 deadline to join class action after FDA clinical hold.

Bahamas becomes first international partner of South Beach Wine & Food Festival, featuring seaplane excursions, themed pavilion, and culinary presentations to promote tourism.

Nvidia's stock stalled this year amid valuation concerns and rising competition in AI chips, though analysts remain optimistic about sector growth and the company's dominant position.

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Robbins LLP files class action suit against Agilon Health for allegedly issuing unachievable 2025 guidance and overstating strategic initiatives, following 50% stock decline.

MTN agrees to acquire IHS Towers for $6.2 billion in all-cash deal, paying $8.50 per share. Transaction consolidates tower infrastructure assets and expected to close in 2026.

January inflation fell to 2.4%, the lowest since May 2025, driven by declining shelter costs. Markets now expect potential Fed rate cuts as early as June 2026.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.

NextEra Energy secures major contracts with Meta and Google, positioning itself as a critical power supplier for AI data centers with 30 gigawatts in backlog.

VTAK acquires 20% stake in Creatd's aviation tech subsidiary Fly Flyte, which provides AI-enabled regional aviation services. Terms not disclosed.

Ormat secures 15-year geothermal power deal with Google via NV Energy, delivering up to 150MW from 2028-2030. Stock surges 5.54% on announcement.

Palo Alto Networks shares fell 2.71% despite announcing the Koi acquisition to boost endpoint security. Analysts remain bullish with a Buy rating and $224 price target.

Medtronic beat Q3 sales estimates at $9.02B with 8.7% growth, reaffirming full-year guidance. Strong cardiovascular and diabetes segments drove performance despite stock decline.